“Attention FIVN Investors: Don’t Miss the Deadline for Lead Plaintiff in Class Action Lawsuit Against Five9 Inc, Reminds Kirby McInerney LLP”

New York Law Firm Kirby McInerney LLP Notifies Investors of Lead Plaintiff Role in Five9, Inc. Securities Class Action Date: January 24, 2025 Source: Globe Newswire The law firm of Kirby McInerney LLP has announced that investors have the opportunity to seek the role of lead plaintiff in a federal securities class action involving Five9,…

Read More

“Unlocking the Potential: Artelo Biosciences Unveils Promising Findings on ART12-11 Tablets, Enhancing Pharmacokinetics Compared to Epidiolex”

Solana Beach: Artelo Biosciences Announces Nonclinical Results on ART12.11 Artelo Biosciences, Inc. recently unveiled exciting nonclinical results on ART12.11, a groundbreaking cocrystal composition of cannabidiol (CBD) and tetramethylpyrazine (TMP). This announcement signifies a significant step forward in the company’s mission to develop innovative treatments for individuals grappling with cancer, pain, dermatological, or neurological conditions. The…

Read More

Revolutionizing Liver Fibrosis Treatment: Carisma Therapeutics Unveils Exciting Preclinical Findings at AASLD’s The Liver Meeting 2024

Revolutionizing Liver Fibrosis Treatment: Carisma Therapeutics Unveils Exciting Preclinical Findings at AASLD’s The Liver Meeting 2024 New Hope for Liver Fibrosis Patients As the field of medicine constantly evolves, new discoveries and breakthroughs are bringing hope to patients suffering from various diseases. One such promising advancement was unveiled by Carisma Therapeutics Inc. at the American…

Read More